Issue Date: January 9, 2017
New strategy to prevent blood clots could come with lower bleeding risk
People with a high risk of suffering from a heart attack or stroke often take drugs that prevent formation of clots in their blood vessels. These drugs have a narrow so-called therapeutic window: Dosages that are high enough to effectively limit harmful clotting can also increase a person’s risk of life-threatening bleeding. A team of researchers at Bristol-Meyers Squibb and the University of Montreal reports a new strategy that could widen that window (Sci. Transl. . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society